Suppr超能文献

通过腺苷铊-201心肌显像测定围手术期心脏风险。

Determination of perioperative cardiac risk by adenosine thallium-201 myocardial imaging.

作者信息

Shaw L, Miller D D, Kong B A, Hilton T, Stelken A, Stocke K, Chaitman B R

机构信息

Department of Internal Medicine, St. Louis University School of Medicine, MO.

出版信息

Am Heart J. 1992 Oct;124(4):861-9. doi: 10.1016/0002-8703(92)90965-x.

Abstract

To determine the predictive value of adenosine thallium-201 myocardial imaging for perioperative cardiac events, 60 consecutive patients referred for preoperative cardiac evaluation were studied before vascular (n = 25), orthopedic (n = 14), or general (n = 21) surgery. Tomographic (n = 52) and planar (n = 8) thallium-201 imaging was performed after adenosine infusion at a rate of 140 micrograms/kg/min for 6 minutes. Two blinded expert observers graded results of adenosine thallium-201 studies as normal (33%), fixed defect only (2%), reversible defect only (48%), and combined (fixed and reversible) defects (17%). After 6 +/- 3 months of follow-up, 81% proceeded to surgery and 43% underwent preoperative coronary angiography. Clinical variables that correlated with perioperative cardiac events were a history of diabetes mellitus (p = 0.05), left bundle branch block (p = 0.02), and left ventricular hypertrophy (p = 0.06) on the resting ECG. This clinically "high-risk" group had an event rate of 22% as compared with no cardiac events in patients in the "low-risk" group without these clinical characteristics (p = 0.005). Stepwise logistic regression analysis revealed that the presence of a combined (fixed and reversible) adenosine thallium-201 defect (p = 0.0007), three-vessel coronary artery disease (p = 0.001), and left bundle branch block (p = 0.02) was predictive of subsequent cardiac events with relative risk ratios of 4.9, 2.9, and 2.2, respectively. Therefore the presence of an adenosine thallium-201 perfusion defect is correlated with and predictive of an increased risk of perioperative cardiac events in patients referred for preoperative risk evaluation.

摘要

为确定腺苷铊-201心肌显像对围手术期心脏事件的预测价值,对60例连续接受术前心脏评估的患者进行了研究,这些患者拟行血管手术(n = 25)、骨科手术(n = 14)或普通外科手术(n = 21)。在以140微克/千克/分钟的速率静脉输注腺苷6分钟后,进行断层(n = 52)和平面(n = 8)铊-201显像。两名盲法专家观察者将腺苷铊-201研究结果分为正常(33%)、仅固定缺损(2%)、仅可逆缺损(48%)和复合(固定和可逆)缺损(17%)。经过6±3个月的随访,81%的患者进行了手术,43%的患者接受了术前冠状动脉造影。与围手术期心脏事件相关的临床变量包括糖尿病病史(p = 0.05)、静息心电图显示左束支传导阻滞(p = 0.02)和左心室肥厚(p = 0.06)。与无这些临床特征的“低风险”组患者无心脏事件相比,这个临床“高风险”组的事件发生率为22%(p = 0.005)。逐步逻辑回归分析显示,复合(固定和可逆)腺苷铊-201缺损(p = 0.0007)、三支冠状动脉疾病(p = 0.001)和左束支传导阻滞(p = 0.02)的存在可预测随后的心脏事件,相对风险比分别为4.9、2.9和2.2。因此,对于接受术前风险评估的患者,腺苷铊-201灌注缺损的存在与围手术期心脏事件风险增加相关且具有预测性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验